arrow

From NeuroLex

Jump to: navigation, search

This table is also available in CSV

Synonym Definition Comment
11-dehydro-thromboxane B2
2-Chloro-Adenosine 5'-diphosphate
2-methylthio adenosine 5'-diphosphate
2-methylthio adenosine 5'-triphosphate
5-oxo-6,8,11,14-eicosatetraenoic acid
AMPA-type glutamate-gated cationic channel AMPA receptor
AMPA
AMPAR
Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. AMPA receptors were originally discriminated from other glutamate receptors by their affinity for the agonist AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid). They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply (MSH).
ANKTM1 ankyrin-like with transmembrane domains 1
ATP-gated ion channel P2X receptor-linked ion channel
ATP2x receptor-linked ion channel
ATP2x receptor
P2X receptor
Acetate
Acetylcholine A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications (MSH).
Acetylcholine-gated channel (nicotinic) Nicotinic acetylcholine receptor
nAChR
This is an acetylcholine binding, cationic channel, which is primarily found on the muscle tissue of vertebrates.
Adenosine 3',5'-cyclic monophosphate
Adenosine 5'-O-(2-fluoro)-diphosphate
Adenosine 5'-O-(2-thio)-diphosphate
Adenosine 5'-O-(3-thio)-triphosphate
Adenosine 5'-diphosphate
Adenosine 5'-monophosphate
Adenosine 5'-triphosphate
Adrenocorticotropic hormone
Adrenomedullin
Alpha bungarotoxin α-bungarotoxin A type of bungarotoxin derived from the venom of the Taiwanese cobra Bugarus multicinctus. It is a peptide of 74 amino acids that bind to the nicotinic acetylcholine receptor with high affiniα-bungarotoxinty.
Alpha-Synuclein DNA The alpha-Synuclein gene is mapped to human chromosome 4q21.3-q22 and organized as seven exons, five of which are protein-coding.
Alpha-Synuclein RNA The alpha-Synuclein mRNA is targeted when researchers target alpha-Synuclein gene expression.
Alpha-ketoglutarate a-ketoglutarate
Alpha-melanocyte stimulating hormone a-melanocyte stimulating hormone
Amino Acid Amino acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins (MSH).
Aminoalkylindole
Amylin
Anaphylatoxin C3a
Anaphylatoxin C5a
Angiotensin
Anionic cys-loop ligand-gated ion channel
Apelin
Arachidonic acid (5Z
8Z
11Z
14Z)-icosa-5
8
11
14-tetraenoic acid
Aspartate HO2CCH(NH2)CH2CO2H
Aspartic acid
the carboxylate anion of aspartic acid and the L-isomer of aspartate is one of the 20 proteinogenic amino acids, i.e., the building blocks of proteins. Its codons are GAU and GAC. (adapted from Wikipedia)
BAM8-22
Beta-Amyloid Amyloid-Beta
Amyloid Beta
Beta Amyloid

Abeta
A 39-43 amino acid peptide composed of 11-15 amino acids of the transmembrance domain of amyloid precursor protein (APP).
Beta-Amyloid 40 Amyloid-Beta 40
Beta-Amyloid 42 Amyloid-Beta 42
Beta-alanine b-alanine
Beta-endorphin b-endorphin
Beta-melanocyte stimulating hormone b-melanocyte stimulating hormone
Beta-phenylethylamine b-phenylethylamine
Bradykinin
Bungarotoxin A polypeptide neurotoxin that is obtained from krait venom and yields three electrophoretic fractions of which the one designated α is used especially to label acetylcholine receptors at neuromuscular junctions because it binds irreversibly to them and blocks their activity —often used with one of the Greek prefixes α-, β-, or γ- to indicate the electrophoretic fractions. (from Merriam-Webster online dictionary)
C Chemokine
C-C Chemokine C-C motif chemokine
C5a des Arg74
CCL1
CCL11 eotaxin
CCL13
CCL14
CCL15
CCL16
CCL17
CCL19
CCL2
CCL20
CCL21
CCL22
CCL23
CCL24
CCL25
CCL26
CCL27
CCL28
CCL3
CCL4
CCL5
CCL7
CCL8
CNGA1 CNG1
CNGa1
RCNC1
CNGA2 OCNC1
CNGa3
CNG2
CNGA3 CNGa2
CNG3
CCNC1
CNGA4 OCNC2
CNG5
CNGB2
CNGa4
CNGB1 CNG4
RCNC2
CNGb1
CNGB3 CNG6
CCNC2
CNGb2
CX3C Chemokine
CX3CL1
CXC Chemokine
CXCL1
CXCL10
CXCL11
CXCL12
CXCL13
CXCL14
CXCL15
CXCL16
CXCL2
CXCL3
CXCL5
CXCL6
CXCL7
CXCL8
CXCL9
Calcitonin
Calcitonin-gene related peptide
Calcium Activated Potassium Channel Potassium channels whose activation is dependent on intracellular calcium concentrations (MSH). We should remove all of the SAO molecule portion of the ontology as these were meant to be placeholders for when we developed NIF molecule.
Calcium Channel Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue (MSH).
Calcium calmodulin protein kinase II
Calcium channel - type 1
Calcium channel - type 2
Calcium channel - type 3 cacna1h
Calcium-activated potassium channel Kca channel
Calcium-activated potassium channel - type 1
Calcium-activated potassium channel - type 2
Calcium-activated potassium channel - type 3
Calcium-activated potassium channel - type 4 IK1; IKCa1; KCa4; Putative Gardos channel; SK4 Intermediate conductance calcium-activated potassium channel protein 4, should I put under
Calcium-activated potassium channel - type 5
Carbohydrate The largest class of organic compounds, including starches, glycogens, cellulose, gums, and simple sugars. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n (MSH).
Carbon monoxide carbonic oxide is produced naturally by the human body. This carbon monoxide may have a physiological role in the body, such as a neurotransmitter or a blood vessel relaxant. Because of carbon monoxide's role in the body, abnormalities in its metabolism have been linked to a variety of diseases, including neurodegenerations, hypertension, heart failure, and inflammation. (from Wikipedia)
Carboxylic acid
CatSper1
CatSper2
CatSper3 CACRC
CatSper4 BN000273
Catecholamine
Cationic cys-loop ligand-gated ion channel
Cav alpha2
Cav alpha2.1
Cav alpha2.2
Cav beta
Cav beta1
Cav beta2
Cav beta3
Cav beta4
Cav delta
Cav delta1
Cav delta2
Cav gamma
Cav gamma1
Cav gamma2
Cav gamma3
Cav gamma4
Cav gamma5
Cav gamma6
Cav gamma7
Cav gamma8
Cav1.1 a1S
skeletal muscle L-type Ca channel
skeletal muscle dihydropyridine receptor
Cav1.2 cardiac or smooth muscle dihydropyridine receptor
a1C
cardiac or smooth muscle L-type Ca channel
Cav1.3 'neuroendocrine' L-type Ca channel
a1D
Cav1.4 a1F
Cav2.1 rBA-1 (rat)
BI-1
Q-type
P-type
a1A
BI-2 (rabbit)
Cav2.2 BIII (rabbit)
a1B
rbB-I
N-type
rbB-II (rat)
Cav2.3 BII-1
rbE-II (rat)
R-type
BII-2 (rabbit)
a1E
Cav3.1 T-type
a1G
CavT.1
Cav3.2 T-type
a1I
Chemokine
Cholecystokinin
Cholic Bile acid
Chondroitin sulfate proteoglycan
Chorionic gonadotropin
Chx10 Chx10
Hox10
Hox-10
C. elegans ceh-10 homeo domain containing homolog
Corticotropin releasing factor CRF
Cortistatin
Cyclic-nucleotide gated channel CNG channel
Cyclic-nucleotide gated channel - type A
Cyclic-nucleotide gated channel - type B
Cys-loop ligand-gated ion channel
Cytidine
Cytidine 5'-diphosphate
Cytidine 5'-monophosphate
Cytidine 5'-triphosphate
D Dopa D-3-(3
4-dihydroxyphenyl)alanine; 3
4-dihydroxy-D-phenylalanine; D-3
4-dihydroxyphenylalanine; (+)-3
4-dihydroxyphenyl)alanine; D-dopa; (2R)-2-amino-3-(3
4-dihydroxyphenyl)propanoic acid; D DOPA; D-Dopa; D-DOPA;
A dopa that has formula C9H11NO4. It is a enantiomer of L-dopa. (Adapted from CHEBI).
DNA Deoxyribonucleic acid A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine) (MSH).
DOPA is a naturally-occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs (e.g., Mucuna pruriens, or velvet bean), and is synthesized from the essential amino acid L-tyrosine (TYR) in the mammalian body and brain. (From Wikipedia)
Deoxycytidine
Deoxyguanosine
Dimeric dimer ion channel
Dimeric ion channel
Dynorphin
Dynorphin A
Eicosanoid lipid
Endorphin
Endothelin
Endothelin 1
Endothelin 2
Endothelin 3
Enkephalin encephalin
Estrogen
Fatty acid long chain carboxylic acid
Follicle-stimulating hormone
GABA Gamma-Aminobutyric acid An amino fatty acid composed of butanoic acid with the amino substituent at C-4; the chief inhibitory neurotransmitter in the mammalian central nervous system (CHEBI)
GABA A-gated anionic channel GABA A receptor
GABAA
GABAA R
GABA-activated chloride channel (anionic) expressed throughout the vertebrate central nervous system, that is modified by many drugs including: GABA; Picrotoxin, convulsants and depressants; barbituates; steroids, volitile compounds and anesthetics; and benzodiazapines and ethanol.
GABA C-gated anionic channel GABA C receptor
GABAC
GABA(C)
GABA-C
An anionic channel, permeable to chloride, that is insensitive to bicuculline and baclofen, but sensitive to GABA and its analogs, including cis-4-aminocrotonic acid (CACA).
GABA-gated anionic channel GABA receptor
GABRA1 GABA-A RECEPTOR; ALPHA-1 POLYPEPTIDE ; GABRA1; Gamma-aminobutyric-acid receptor subunit alpha-precursor; Gamma-aminobutyric-acid receptor subunit alpha-1 taken from OMIM
GABRA2 GABA(A) receptor subunit alpha-2; Gamma-aminobutyric-acid receptor subunit alpha-2 precursor; Gamma-aminobutyric-acid receptor subunit alpha-2; GABA-A RECEPTOR
ALPHA-2 POLYPEPTIDE; GAMMA-AMINOBUTYRIC ACID RECEPTOR
ALPHA-2
Gamma-aminobutyric-acid receptor subunit alpha-2
taken from OMIM
GABRA3 GAMMA-AMINOBUTYRIC ACID RECEPTOR
ALPHA-3; GABA-A RECEPTOR
ALPHA-3 POLYPEPTIDE; Gamma-aminobutyric-acid receptor subunit alpha-3 precursor; Gamma-aminobutyric-acid receptor subunit alpha-3
taken from OMIM
GABRA4 Gamma-aminobutyric-acid receptor subunit alpha-4 precursor; Gamma-aminobutyric-acid receptor subunit alpha-4; GAMMA-AMINOBUTYRIC ACID RECEPTOR
ALPHA-4; GABA-A RECEPTOR
ALPHA-4 POLYPEPTIDE;
taken from OMIM
GABRA5 Gamma-aminobutyric-acid receptor subunit alpha-5 precursor; Gamma-aminobutyric-acid receptor subunit alpha-5
GAMMA-AMINOBUTYRIC ACID RECEPTOR
ALPHA-5
GABA-A RECEPTOR
ALPHA-5 POLYPEPTIDE
taken from OMIM
GABRA6 Gamma-aminobutyric-acid receptor subunit alpha-6 precursor; Gamma-aminobutyric-acid receptor subunit alpha-6; GAMMA-AMINOBUTYRIC ACID RECEPTOR
ALPHA-6; GABA-A RECEPTOR
ALPHA-6 POLYPEPTIDE
taken from OMIM
GABRB1 GABA(A; Gamma-aminobutyric-acid receptor subunit beta-precursor; Gamma-aminobutyric-acid receptor subunit beta-1; GAMMA-AMINOBUTYRIC ACID RECEPTOR
BETA-1; GABA-A RECEPTOR
BETA-1 POLYPEPTIDE
taken from OMIM
GABRB2 GABA(A; Gamma-aminobutyric-acid receptor subunit beta-2 precursor; Gamma-aminobutyric-acid receptor subunit beta-2; GAMMA-AMINOBUTYRIC ACID RECEPTOR
BETA-2; GABA-A RECEPTOR
BETA-2 POLYPEPTIDE; Gamma-aminobutyric acid type B receptor
subunit 2
taken from OMIM
GABRB3 GABA(A; Gamma-aminobutyric-acid receptor subunit beta-3 precursor; Gamma-aminobutyric-acid receptor subunit beta-3; GAMMA-AMINOBUTYRIC ACID RECEPTOR
BETA-3; GABA-A RECEPTOR
BETA-3 POLYPEPTIDE
taken from OMIM
Galanin
Gamma secretase A protein complex containing presenilin, nicastrin, ACH-1, and PEN-2. Presenilin is believed to harbor the protease domain and represents an important example of an uncommon type of protease that cleaves targets within the cell membrane.
Gamma-melanocyte stimulating hormone g-melanocyte stimulating hormone
gamma-MSH
Ganglioside
Gastric inhibitory polypeptide
Gastrin
Gastrin-releasing peptide
Gene Genes A region (or regions) that includes all of the sequence elements necessary to encode a functional transcript. A gene may include regulatory regions, transcribed regions and/or other functional sequence regions.
Ghrelin
GluCl glutamate-gated chloride channel GluCl glutamate receptor; Avermectin- sensitive glutamate-gated chloride channel subunit; Glu-Cl beta subunit; Glutamate-gated chloride channel subunit beta precursor; Glutamate-gated chloride channel subunit beta
GluR1
GluR2 gria2
dkfzp459f083
glur2
glur-2
glur-b
glur-k2
mgc139795
glurb
hbgr2
GluR3
Glucocorticoid A steroid hormone that regulates a variety of physiological processes, in particular control of the concentration of glucose in blood.
Glucose
Glutamate Glut The carboxylate anion of glutamic acid; and the major excitatory neurotransmitter in the central nervous system of vertebrates, the peripheral nervous system of invertebrates.
Glutamate-gated cationic channel Glutamate receptor
GluR
Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases (MSH).
Glycine 2-Aminoacetic acid
Aminoacetic acid
Aminoethanoic acid
Gly
Aciport
Glicoamin
Glycocoll
Glycolixir
Glycosthene
Gyn-Hydralin
Padil
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. (PubChem) Pharmacology: Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system. Mechanism of action: In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. Drug type: Approved. Nutraceutical. Small Molecule. Drug category: Dietary supplement. Glycine Agents. Micronutrient. Non-Essential Amino Acids taken from DrugBank
Glycine-gated chloride channel Glycine receptor; GABA-gated chloride channel subunit
Glycogen
Glycoprotein A compound in which a carbohydrate component is covalently bound to a protein component.(CHEBI)
Gonadotrophin-releasing hormone gonadorelin; Gonadotropin-releasing hormone; Luteinizing-hormone releasing hormone; GnRH receptor; GnRH-R; Gonadotropin-releasing hormone receptor
Growth hormone-releasing hormone
Guanosine
Guanosine 3',5'-cyclic monophosphate A nucleotide synthesized by the enzyme guanylyl cyclase. This nucleotide acts to modify proteins in two ways. By binding directly to proteins such as cGMP-sensitive cation channels in the retina, and by protein phosphorylation through the cGMP-dependent protein kinase.
Guanosine 5'-diphosphate
Guanosine 5'-monophosphate
Guanosine 5'-triphosphate
HCN1 HAC2
BCNG1
HCN2 BCNG2
HAC1
HCN3 HAC3
BCNG4
HCN4 BCNG3
HAC4
Histamine is produced by basophils and mast cells (in connective tissues) and is involved in local immune responses and regulating physiological function in the gut and acting as a neurotransmitter. - adapted from Wikipedia
Histamine-gated chloride channel
Hyperpolarization and cyclic-nucleotide gated channel HCN channel
IP3R Type 1
IP3R Type 2
IP3R Type 3
Inositol 1 4 5 Trisphosphate Receptor
Insulin-like peptide
Insulin-like peptide 5
Intracellular Calcium Channel
Inwardly rectifying potassium channel Kir channel
Inwardly rectifying potassium channel - type 1
Inwardly rectifying potassium channel - type 2
Inwardly rectifying potassium channel - type 3
Inwardly rectifying potassium channel - type 4
Inwardly rectifying potassium channel - type 5
Inwardly rectifying potassium channel - type 6
Inwardly rectifying potassium channel - type 7
Ion channel
K2p1.1 TWIK-1
hONO
KCNK1
K2p10.1 TREK-2
KCNK10
K2p12.1 THIK-2
KCNK12
K2p13.1 KCNK13
THIK-1
K2p15.1 TASK-5
KCNK15
KT3.3
K2p16.1 TALK-1
KCNK16
K2p17.1 KCNK17
TALK-2
TASK-4
K2p18.1 TRIK
K2p2.1 KCNK2
TPKC1
TREK-1
K2p3.1 TASK-1
KCNK3
TBAK-1
OAT-1
K2p4.1 KCNK4
TRAAK
K2p5.1 TASK-2
KCNK5
K2p6.1 TWIK-2
KCNK6
TOSS
K2p7.1 KCNK7
kcnk8
K2p9.1 KCNK9
TASK-3
KCa beta
KCa beta1
KCa beta2
KCa beta3
KCa beta4
Kainate glutamate-gated cationic channel Kainate receptor Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Kainate receptors directly control ion channels and have also been implicated in the mechanisms of disease (MSH).
There are five types of kainate receptor subunits, GluR5 (GRIK1), GluR6 (GRIK2), GluR7 (GRIK3), KA1 (GRIK4) and KA2 (GRIK5), which are similar to AMPA and NMDA receptor subunits and can be arranged in different ways to form a tetramer, a four subunit receptor. GluR5-7 can form homomers (ex. a receptor composed entirely of GluR5) and heteromers (ex. a receptor composed of both GluR5 and GluR6), however, KA1 and KA2 can only form functional receptors by combining with one of the GluR5-7 subunits.
Each KAR subunit begins with an extracellular N-terminal segment, which forms part of the neurotransmitter binding cleft called S1. This segment then passes through the cell membrane, forming the first of three membrane spanning regions called M1. The M2 segment then begins on the cytoplasmic face of the membrane, pushes into the cell membrane about half way, and then dips back out to the cytoplasm. This segment has been termed the "p loop", and as is the case of closely related AMPA receptors, determines the calcium permeability of the receptor. M2 turns into M3, another transmembrane spanning segment which emerges on the extracellular face to complete the neurotransmitter binding site (a portion called S2). M4 begins extracellularly, and passes again through the membrane into the cytoplasm, forming the C-terminal of the protein.
Kca1.1 KCNMA1; Slo; maxi K+ channel; BK channel;BKCA alpha; Calcium-activated potassium channel
subfamily M subunit alpha 1; K(VCA)alpha; KCa1.1; Maxi K channel; MaxiK; Slo homolog; Slo-alpha; Slo1; Slowpoke homolog; hSlo; Calcium-activated potassium channel subunit alpha 1
The large-conductance voltage- and Ca(2+)-activated K+ channel, also called the BK channel, differs from other K+ channels in that it can be activated by both intracellular Ca(2+) ions and by membrane depolarization. The BK channel consists of 4 alpha subunits and 4 optional auxiliary beta subunits. The pore-forming alpha subunit is encoded by the KCNMA1 gene, which produces multiple isoforms through alternative splicing. The 4 beta subunits are encoded by different genes that show tissue-specific expression
Kca2.1 KCNN1
SKCa1
SK1
Kca2.2 SKCa2
KCNN2
SK2
Kca2.3 KCNN3
SK3
hKCa3
SKCa3
Kca3.1 KCNN4
SK4
IK1
Gardos channel
IKCa1
KCa4
Kca4.1 mSlo2
Slack
Kca4.2
Kca5.1 Slo3
KCNMC1
KiSS-1 gene product
Kir1.1 ROMK1; ATP-regulated potassium channel ROM-K; Kir1.1; Potassium channel
inwardly rectifying subfamily J member 1; ATP-sensitive inward rectifier potassium channel 1
Kir2.1 IRK1
Kir2.2 IRK2; IRK2; Inward rectifier K(+) channel Kir2.2v; Kir2.2v; Potassium channel
inwardly rectifying subfamily J member 12; ATP-sensitive inward rectifier potassium channel 12
Kir2.3 hIRK2
IRK3
HIR
HRK1
Kir2.4 IRK4
Kir3.1 KGA
GIRK1; GIRK1; Inward rectifier K(+) channel Kir3.1; Potassium channel
inwardly rectifying subfamily J member 3; G protein-activated inward rectifier potassium channel 1
Kir3.2 GIRK2; BIR1; GIRK2; Inward rectifier K(+) channel Kir3.2; KATP-2; Potassium channel
inwardly rectifying subfamily J member 6; G protein-activated inward rectifier potassium channel 2
Kir3.3 GIRK3
Kir3.4 GIRK4
Kir4.1 BIR10
KAB-2
Kir1.2
Kir4.2 Kir1.3
ROMK3
Kir5.1
Kir6.1 uKATP-1; Inwardly rectifier K(+) channel Kir6.1; Potassium channel
inwardly rectifying subfamily J member 8; uKATP-1; ATP-sensitive inward rectifier potassium channel 8
Kir6.2 BIR; IKATP; Inward rectifier K(+) channel Kir6.2; Potassium channel
inwardly rectifying subfamily J member 11; ATP-sensitive inward rectifier potassium channel 11
Kir7.1
Kv beta
Kv beta1
Kv beta2
Kv beta3
Kv1.1 MBK1
MK1
HBK1
RBK1
RCK1
HuK(I)
Kv1.2 HuK(IV)
NGK1
RAK
MK2
HBK5
RCK5
BGK5
XSha2
BK2
Kv1.3 MBK3
MK3
hPCN3
HGK5
RGK5
RCK3
HLK3
HuK(III)
KV3
Kv1.4 HK1
HuK(II)
RCK4
RHK1
hPCN2
RK8
MK4
RK4
Kv1.5 HK2
RMK2
HuK(II)
HCK1
hPCN1
fHK
KV1
RK3
Kv1.6 KCNA6
KV2
HBK2
RCK2
MK1.6
Kv1.7 KCNA7
Kv1.8 KCNA10
Kv1.10
Kcn1
Kv10.1 ether-a-go-go
KCNH1b
eag1a
KCNH1a
eag1b
Kv10.2 eag2
KCNH5
Kv11.1 KCNH2
HERG
erg1
Hergb
human ether-a-go-go-related gene
Kv11.2 erg2
Kv11.3 erg3
Kv12.1 elk1
elk3
Kv12.2 BEC1
KCNH3
Elk2
Kv12.3 elk1
BEC2
KCNH4
Kv2.1 DRK1
hDRK1
Kv2.2 CDRK
KCNB2
Kv3 Shaw-like family of voltage gated potassium channels.
Kv3.1 NGK2
Kv3.1
type I channel in T cells
KV4
Raw2
Kv3.2 rKv3.2b
rKv3.2c
Kv3.2a
RKShIIIA
Raw1
Kv3.2 (sao1482557638)
Kv3.3 Kv3.3b
hKv3.3
mKv3.3
RKShIIID
Kv3.4 HKShIIIC
mKv3.4
Raw3
Kv4.1 mShal
Kv4.2 RK5
Shal1
Kv4.3
Kv5.1 IK8
KH1
KCNF1
Kv6.1 K13
KH2
Kv6.2 KCNG2
Kv6.3 KCNG3
Kv10.1
Kv6.4
Kv7.1 KVLQT1
slow delayed rectifier
Kv7.2 KQT2
KCNQ2
Kv7.3 KCNQ3
Kv7.4 KCNQ4
Kv7.5 KCNQ5
Kv8.1 Kv2.3
HNKA
Kv8.2
Kv9.1
Kv9.2
Kv9.3
Laminin complex Laminin A large, extracellular glycoprotein complex composed of three different polypeptide chains, alpha, beta and gamma. Provides an integral part of the structural scaffolding of basement membranes.
Lectin
Leu enkephalin leucine enkephalin One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN (MeSH)
Leukotriene
Leukotriene B4
Leukotriene C4
Leukotriene D4
Levodopa 3
4-dihydroxyphenylalanine
DOPA
L-DOPA
L-Dopa
L-Dihydroxyphenylalanine
Bendopa
Brocadopa
Cidandopa
Deadopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopalina
Dopar
Doparkine
Doparl
Dopasol
Dopaston
Dopastral
Doprin
Eldopal
Eldopar
Eldopatec
Eurodopa
Helfo-Dopa
Insulamina
Laradopa
Larodopa
Ledopa
Levedopa
Levopa
Maipedopa
Parda
Pardopa
Prodopa
Syndopa
Veldopa
Weldopa; beta-(3
4-dihydroxyphenyl)alanine; (2S)-2-amino-3-(3
4-dihydroxyphenyl)propanoic acid; (-)-dopa; (-)-3-(3
4-dihydroxyphenyl)-L-alanine; levodopum; Dopar; L-DOPA; beta-(3
4-dihydroxyphenyl)-L-alanine; L-Dopa; 3
4-Dihydroxy-L-phenylalanine; 3-Hydroxy-L-tyrosine; L-beta-(3
4-Dihydroxyphenyl)alanine; Dihydroxy-L-phenylalanine; 3
4-DIHYDROXYPHENYLALANINE; C9H11NO4;
An amino acid precursor of dopamine with antiparkinsonian properties. L-DOPA is a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. When in the brain, L-DOPA is decarboxylated to dopamine and stimulates the dopaminergic receptors. (Adapted from NCI Thesaurus) Levodopa is naturally occurring form of dihydroxyphenylalanine and the immediate precursor of dopamine. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonian disorders and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. (PubChem) Pharmacology: Levodopa (L-dopa) is used to replace dopamine lost in Parkinson's disease because dopamine itself cannot cross the blood-brain barrier where its precursor can. However, L-DOPA is converted to dopamine in the periphery as well as in the CNS, so it is administered with a peripheral DDC (dopamine decarboxylase) inhibitor such as carbidopa, without which 90% is metabolised in the gut wall, and with a COMT inhibitor if possible; this prevents about a 5% loss. The form given therapeutically is therefore a prodrug which avoids decarboxylation in the stomach and periphery, can cross the blood-brain barrier, and once in the brain is converted to the neurotransmitter dopamine by the enzyme aromatic-L-amino-acid decarboxylase. Mechanism of action: Striatal dopamine levels in symptomatic Parkinson's disease are decreased by 60 to 80%, striatal dopaminergic neurotransmission may be enhanced by exogenous supplementation of dopamine through administration of dopamine's precursor, levodopa. A small percentage of each levodopa dose crosses the blood-brain barrier and is decarboxylated to dopamine. This newly formed dopamine then is available to stimulate dopaminergic receptors, thus compensating for the depleted supply of endogenous dopamine. Drug type: Approved. Small Molecule. Drug category: Antidyskinetics. Antiparkinson Agents. Dopamine Agents taken from DrugBank
Lipid A substances of biological origin that is soluble in nonpolar solvents, consisting of saponifiable lipids, such as glycerides (fats and oils) and phospholipids, as well as nonsaponifiable lipids, principally steroids (adapted from CHEBI).
Lipopolysaccharide Natural compound consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Lipoprotein A clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
Lipoxin
Lipoxin A
Lipoxin A4
Lipoxin B
Lipoxin B4
Luteinizing hormone
Lysophosphatidic acid
Lysophospholipid
MRNA RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm (MSH).
Macromolecular complex
Macromolecule
Macrophage derived lectin
Melanin-concentrating hormone
Melanocyte stimulating hormone
Met enkephalin methionine enkephalin One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN (MeSH)
MinK-like
MinK-like 1
MinK-like 2
MinK-like 3
MinK-like 4
MinK-like 5
Mitochondrial DNA Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial genome is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins (MSH).
Monoamines
Monomeric Voltage-gated ion channel
Monomeric ion channel
Motilin
Multimeric Voltage-gated ion channel Voltage-gated ion channel
Multimeric ion channel
N-formyl-L-Met-L-Leu-L-Phe
NG2
NMDA-type glutamate-gated cationic channel NMDA receptor
NMDA
NMDAR
Tetrameric receptor, consisting of two glycine binding NR1 subunits and two glutamate binding NR2 subunits. The glycine-binding NR3 subunits can also assemble with NR2 subunits. NR1 and NR3 subunits assemble only in xenopus oocytes to form a glycine gated receptor.

NMDA receptors bind glutamate, aspartate, NMDA, NMDA receptors' conductance is modified by glycine, Magnesium, Zinc and 2-amino-5-phosphonovalerate (APV)

Laube et al., suggest that the recombinant NMDA receptor is a tetramer (PMID: 9526012, also see PMID: 18779583).
Nav beta
Nav beta1
Nav beta2
Nav beta3
Nav beta4
Nav1.1 brain type I; rat I; R-I; Sodium channel protein type I subunit alpha; Sodium channel protein
brain I subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.1; Sodium channel protein type subunit alpha
Nav1.2 R-II; brain type II; rat II; HBSC II; Sodium channel protein type II subunit alpha; Sodium channel protein
brain II subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.2; Sodium channel protein type 2 subunit alpha
Nav1.3 rat 3; brain type 3; R-III; Sodium channel protein type III subunit alpha; Sodium channel protein
brain III subunit alpha; Voltage- gated sodium channel subtype III; Voltage-gated sodium channel subunit alpha Nav1.3; Sodium channel protein type 3 subunit alpha
Nav1.4 SkM1; m1; SkM1; Sodium channel protein type IV subunit alpha; Sodium channel protein
skeletal muscle subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.4; Sodium channel protein type 4 subunit alpha
Nav1.5 skm II; hI; cardiac sodium channel; HH1; Sodium channel protein type V subunit alpha; Sodium channel protein
cardiac muscle alpha-subunit; Voltage-gated sodium channel subunit alpha Nav1.5; Sodium channel protein type 5 subunit alpha
Nav1.6 NaCh6; PN4; CerIII; Sodium channel protein type VIII subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.6; Sodium channel protein type 8 subunit alpha
Nav1.7 Nas; hNE-Na; PN1; Neuroendocrine sodium channel; Peripheral sodium channel 1; Sodium channel protein type IX subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.7; hNE-Na Sodium channel protein type 9 subunit alpha
Nav1.8 SNS; PN3; Peripheral nerve sodium channel 3; Sodium channel protein type X subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.8; hPN3; Sodium channel protein type 10 subunit alpha
Nav1.9 NaN; SNS-2; Peripheral nerve sodium channel 5; Sensory neuron sodium channel 2; Sodium channel protein type XI subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.9; hNaN; Sodium channel protein type 1subunit alpha
Nax NaG
Atypical sodium channel
Nesfatin 1 An 82 amino acid peptide that suppresses food intake after intracerebroventricular injection (MeSH)
Neurofilament 150kD mRNA Neurofilament Medium mRNA
NF-M mRNA
Neurofilament 200kD mRNA Neurofilament Heavy mRNA
NF-H mRNA
Neurofilament 68kD mRNA Neurofilament Light mRNA
NF-L mRNA
Neurokinin
Neurokinin A
Neurokinin B
Neuromedin B
Neuromedin U
Neuropeptide B
Neuropeptide FF
Neuropeptide S
Neuropeptide W
Neuropeptide Y
Neuropeptide head activator
Neurotensin
Nicotinic acid pyridine-3-carboxylic acid
Nociceptin orphanin FQ
Nuclear DNA
Nucleic Acid High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages (MSH).
Nucleoside
Nucleotide
Obestatin
Oleoylethanolamide
Opioid peptide
Orexin hypocretin A protein that is a translation product of the HCRT gene or a 1:1 ortholog thereof. (PRO:000008476)
Orexin A hypocretin 1
Orexin B hypocretin 2
Oxytocin Pitocin
Syntocinon
Oxytocin (BAM Biotech)
Pitocin (Parke-Davis)
Syntocinon (Sandoz)
Synthetic 9 residue cyclic peptide. The hormone is prepared synthetically to avoid possible contamination with vasopressin (ADH) and other small polypeptides with biologic activity. Pharmacology: Used to induce labor or to enhance uterine contractions during labor. Uterine motility depends on the formation of the contractile protein actomyosin under the influence of the Ca2+-dependent phosphorylating enzyme myosin light-chain kinase. Oxytocin promotes contractions by increasing the intracellular Ca2+, which in turn activates myosins light chain kinase.. Oxytocin has specific receptors in the muscle llining of the uterus and the receptor concentration increases greatly during pregnancy, reaching a maximum in early labor at term. Mechanism of action: Binds the oxytocin receptor which leads to an increase in intracellular calcium levels. Drug type: Approved. Biotech. Drug category: Anti-tocolytic Agents. Labor Induction Agents. Oxytocics taken from DrugBank
P2x1
P2x2
P2x3
P2x4
P2x5
P2x6
P2x7
Pancreatic polypeptide
Parathyroid hormone
Pentameric ion channel
Peptide A short polymers of amino acids. Although somewhat arbitrary, peptides are generally less than 50 amino acids in length.
Phalloidin Phalloidin is a peptide derived from the Death Cap mushroom that acts as a toxin by binding actin, inhibiting its depolymerization. Phalloidin binds specifically F-actin and is therefore a very convenient tool to investigate the distribution of F-actin since fluorescent analogs can be synthesized that retain actin binding. (Wikipedia)
Phaseolus vulgaris leucoagglutinin A plant lectin used extensively as an anterograde tracer in central nervous system tract tracting studies
Phospholipid
Pituitary Adenylate Cyclase activating polypeptide
Platelet-activating factor
Potassium Channel Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits (MSH).
Prokineticin
Prokineticin 1
Prokineticin 2
Prolactin-releasing peptide
Prostacyclin
Prostaglandin D2
Prostaglandin E2
Prostaglandin F2a
Prostaglandin lipid
Prostanoid lipid
Proteasome A large multisubunit complex which catalyzes protein degradation. This complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core.
Protein complex
Proteoglycan
Purine Nucleoside
Purine Nucleotide
Pyrimidine Nucleoside
Pyrimidine Nucleotide
RF-amide P518 gene product
RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) (MSH)
RSlo
Relaxin
Relaxin 3 Relaxin-3
Resolvin E1
Retinoic acid receptor responder
Retinoic acid receptor responder (tazarotene induced) 2
Ribosomal RNA The most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50% of the ribosome. (Dorland, 28th ed) (MSH)
Ryanodine Receptor RYR-1; RyR1; Skeletal muscle calcium release channel; Skeletal muscle-type ryanodine receptor; Ryanodine receptor 1 Protein complexes that mediate the release of calcium from the sarcoplasmic reticulum in both skeletal and cardiac muscle cells by forming tetrametric complexes. These complexes each then act as a calcium channel. There are three isoforms of the RyR: RyR1, RyR2, and RyR3. RyR1 is specifically expressed in skeletal muscles and RyR2 in cardiac muscles. RyR3 is yet another isoform found in non-muscle cells such as neuronal cells. (From Yonsei Med J 1996;37(1):72-80) (MSH)
SLO-2 SLO-2 is a member of a multigene family of high-conductance K+ channels1,2. These channels are activated by voltage but differ from the purely voltage-gated K+ channels because their voltage range of activation is modulated by different intracellular fac- tors3. SLO-1 channels are sensitive to Ca2+ (refs. 4–7), and mouse SLO-3 (mSLO-3) channels to pH8. We now report that C. elegans SLO-2 channels are sensitive to Cl– as well as Ca2+.
SMN2
Serine protease
Serotonin 5-hydroxytryptamine
5-HT; 5HT transporter; 5HTT; Sodium-dependent serotonin transporter
A biochemical messenger and regulator, synthesized from the essential amino acid L-tryptophan. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (receptors, serotonin) explain the broad physiological actions and distribution of this biochemical mediator (MSH).
Serotonin-gated anionic channel 5-HT mod-1 receptor
Serotonin receptor mod-1
Serotonin-gated channel (5-HT3) Serotonin 5-HT3 receptor; 5-HT-3; 5-HT3R; 5-hydroxytryptamine 3 receptor precursor; Serotonin-gated ion channel receptor
5-hydroxytryptamine 3 receptor
Sodium Channel Cell membrane glycoproteins selective for sodium ions. Fast sodium current is associated with the action potential in neural membranes (MSH).
Sodium channel - type 1
Somatostatin
Somatostatin (nifext 5116)
Sphingolipid
Sphingosine
Sphingosine 1-phosphate
Steroid
Substance P
Succinate
Survival motor neuron protein complex SMN protein complex A protein complex that contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and Unrip proteins; the complex is found in the cytoplasm and in nuclear Gems, and is involved in spliceosomal snRNP assembly in the cytoplasm and in pre-mRNA splicing in the nucleus.
TPC1 two-pore channel-1
TPC2 two-pore channel-2
TRPC1 TRP1
TRPC2
TRPC3 mTRPC3
TRPC4 bCCE
CCE1
TRP4
TRPC5 TRP5
CCE2
TRPC6
TRPC7 TRP7
TRPM1
TRPM2 LTRPC2
TRPC7
TRPM3 LTRPC3
MLSN2
TRPM4
TRPM5 MTR1
LTRPC5
TRPM6 ChaK2
TRPM7 LTRPC7
TRP-PLIK
ChaK(1)
TRPM8 CMR1
Trp-p8
TRPML1 mucolipin 1
TRPML2 mucolipin 2
TRPML3 mucolipin 3
TRPP1 polycystic kidney disease 2
polycystin-2
TRPP2 polycystic kidney disease 2-like 1
TRPP3 polycystic kidney disease 2-like 2
TRPV1 OTRPC1; VR1; Capsaicin receptor; OTRPC1; TrpV1; Vanilloid receptor 1; osm-9-like TRP channel 1; Transient receptor potential cation channel subfamily V member 1
TRPV2 GRC
VRL-1
OTRPC2
TRPV3 TrpV3; VRL-3; Vanilloid receptor-like 3; Transient receptor potential cation channel subfamily V member 3
TRPV4 OTRPC4
VR-OAC
TRPV5 ECaC1
CaT2
TRPV6 CaT1
ECaC2
Tazarotene-induced Gene 2
Tetrameric Voltage-gated ion channel
Tetrameric ion channel
Thrombin
Thromboxane
Thromboxane A2
Thymidine
Thyroid-stimulating hormone
Thyrotropin-releasing hormone
Transient receptor potential channel TRP channel
Transient receptor potential channel - type C
Transient receptor potential channel - type M
Transient receptor potential channel - type V
Transient receptor potential related channel
Transient receptor potential related channel - PKD type
Transient receptor potential related channel - mucolipin type
Transient receptor potential related channel - sperm-specific Ca+2-selective type
Transient receptor potential related channel - two-pore type
Trimeric ion channel
Tuberoinfundibular peptide of 39 residues
Two pore potassium channel K2p channel
Two pore potassium channel - type 1
Two pore potassium channel - type 10
Two pore potassium channel - type 12
Two pore potassium channel - type 13
Two pore potassium channel - type 15
Two pore potassium channel - type 16
Two pore potassium channel - type 17
Two pore potassium channel - type 18
Two pore potassium channel - type 2
Two pore potassium channel - type 3
Two pore potassium channel - type 4
Two pore potassium channel - type 5
Two pore potassium channel - type 6
Two pore potassium channel - type 7
Two pore potassium channel - type 9
Tyramine
Uridine
Uridine 5'-O-(3-thio)-triphosphate
Uridine 5'-diphosphate
Uridine 5'-diphosphate-glucose
Uridine 5'-monophosphate
Uridine 5'-triphosphate
Urocortin
Urotensin II
VGCNL1 voltage-gated channel like 1
Vasoactive intestinal peptide Vasoactive intestinal polypeptide Vasoactive intestinal peptide is a peptide hormone containing 28 amino acid residues
Vasopressin 3-Isoleucyl vasopressin
Arginine oxytocin
Arginine vasotocin
Argiprestocin
Pitressin tannate
Vasopressin
isoleucyl
non-mammalian
Vasotocin
Pitressin
Pressyn
Antidiuretic hormone, also known as vasopressin, is a nine amino acid peptide secreted from the posterior pituitary. Antidiuretic hormone binds to receptors in the distal or collecting tubules of the kidney and promotes reabsorbtion of water back into the circulation Pharmacology: Vasopressin is an antidiuretic hormone indicated for the prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows, and in diabetes insipidus. Vasopressin can cause contraction of smooth muscle of the gastrointestinal tract and of all parts of the vascular bed, especially the capillaries, small arterioles and venules. It has less effect on the smooth musculature of the large veins. Vasopressin may also be used to control bleeding in some forms of von Willebrand disease and to treat extreme cases of bed wetting in children. It may also play a role in memory formation although the mechanism is unknown. Mechanism of action: Vasopressin acts on three different receptors, vasopressin receptor V1a (which initiates vasoconstriction, liver gluconeogenesis, platelet aggregation and release of factor VIII), vasopressin receptor V1b (which mediates corticotrophin secretion from the pituitary) and vasopressin receptor V2 which controls free water reabsorption in the renal medullar. The binding of vasopressin to the V2 receptor activates adenylate cyclase which causes the release of aquaporin 2 channels into the cells lining the renal medullar duct. This allows water to be reabsorbed down an osmotic gradient so the urine is more concentrated. Drug type: Approved. Biotech. Drug category: Antidiuretics. Oxytocics. Vasoconstrictor Agents taken from DrugBank
Voltage Gated Potassium Channel Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the action potential (MSH).
Voltage Gated Sodium Channel A sodium channel in a cell membrane whose opening is governed by the membrane potential (Gene Ontology).
Voltage-gated calcium channel calcium channel
Cav channel
Ca+2 channel
Ca++ channel
Voltage-gated potassium channel K+ channel
IK
I K
Ik
Potassium channel
Activated by strong depolarization; delayed rectifier Repolarization of action potential
Voltage-gated potassium channel - type 1
Voltage-gated potassium channel - type 10
Voltage-gated potassium channel - type 11
Voltage-gated potassium channel - type 12
Voltage-gated potassium channel - type 2
Voltage-gated potassium channel - type 3
Voltage-gated potassium channel - type 4
Voltage-gated potassium channel - type 5
Voltage-gated potassium channel - type 6
Voltage-gated potassium channel - type 7
Voltage-gated potassium channel - type 8
Voltage-gated potassium channel - type 9
Voltage-gated sodium channel Na+ channel
sodium channel
Nav channel
Wheat germ agglutinin A lectin that protects wheat (Triticum vulgaris) from insects, yeast and bacteria. An agglutinin protein, it binds to N-acetyl-D-glucosamine and Sialic acid. N-acetyl-D-glucosamine in the natural environment of wheat is found in the chitin of insects, and the cell membrane of yeast & bacteria. WGA is found abundantly—but not exclusively—in the wheat kernel, where it got the 'germ' name from (adapted from Wikipedia: http://en.wikipedia.org/wiki/Wheat-germ_agglutinin).
Wnt peptide
Wnt1 peptide
Wnt2 peptide
Wnt3 peptide
Wnt3a peptide
XCL1
XCL2

Contributors

Admin, Akash, Memartone, Slarson, Smaynard



bookmark

*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.